Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going von Russo, A., Franchina, T., Ricciardi, G.R.R., Smiroldo, V., Picciotto, M., Zanghì, M., Rolfo, C., Adamo, V.

Volltext

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer von Scagliotti, G V, De Marinis, F, Rinaldi, M, Crinò, L, Gridelli, C, Ricci, S, Matano, E, Boni, C, Marangolo, M, Failla, G, Altavilla, G, Adamo, V, Ceribelli, A, Clerici, M, Di Costanzo, F, Frontini, L, Tonato, M

Volltext

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scen... von Cantini, L., Mentrasti, G., Russo, G.L., Signorelli, D., Pasello, G., Rijavec, E., Russano, M., Antonuzzo, L., Rocco, D., Giusti, R., Adamo, V., Genova, C., Tuzi, A., Morabito, A., Gori, S., Verde, N. La, Chiari, R., Cortellini, A., Cognigni, V., Pecci, F., Indini, A., De Toma, A., Zattarin, E., Oresti, S., Pizzutilo, E.G., Frega, S., Erbetta, E., Galletti, A., Citarella, F., Fancelli, S., Caliman, E., Della Gravara, L., Malapelle, U., Filetti, M., Piras, M., Toscano, G., Zullo, L., De Tursi, M., Di Marino, P., D’Emilio, V., Cona, M.S., Guida, A., Caglio, A., Salerno, F., Spinelli, G., Bennati, C., Morgillo, F., Russo, A., Dellepiane, C., Vallini, I., Sforza, V., Inno, A., Rastelli, F., Tassi, V., Nicolardi, L., Pensieri, V., Emili, R., Roca, E., Migliore, A., Galassi, T., Rocchi, M. L. Bruno, Berardi, R.

Volltext

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial von Lonardi, S, Sobrero, A, Rosati, G, Di Bartolomeo, M, Ronzoni, M, Aprile, G, Massida, B, Scartozzi, M, Banzi, M, Zampino, M G, Pasini, F, Marchetti, P, Cantore, M, Zaniboni, A, Rimassa, L, Ciuffreda, L, Ferrari, D, Barni, S, Zagonel, V, Maiello, E, Rulli, E, Labianca, R

Volltext

The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy von Russo, A., Franchina, T., Ricciardi, G.R.R., Toscano, G., Schifano, S., Lo Certo, G., Battaglia, A., Pantò, E., Scaffidi Fonti, M., Adamo, V.

Volltext

The role of Aurora-A inhibitors in cancer therapy von Agnese, V, Bazan, V, Fiorentino, FP, Fanale, D, Badalamenti, G, Colucci, G, Adamo, V, Santini, D, Russo, A

Volltext

Photography as a therapeutic tool to re-elaborate “cancer” experience von Franchina, V., Ceravolo, F.L., Franchina, T., Ricciardi, G.R.R., Adamo, V.

Volltext

1893 The role of Androgen Receptor, E-cadherin and Ki67 as novel prognostic markers in Triple Negative Breast Cancer (TNBC) von Ricciardi, G, Adamo, B, Barresi, V, Ieni, A, Franchina, T, Caruso, M, Zacchia, A, Fazzari, C, Tuccari, G, Adamo, V

Volltext

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project von CRINO, L, SCAGLIOTTI, G. V, SASSI, M, BARNI, S, RAVAIOLI, A, ADAMO, V, PORTALONE, L, CRUCIANI, G, MASOTTI, A, FERRARA, G, GOZZELINO, F, TONATO, M, RICCI, S, DE MARINIS, F, RINALDI, M, GRIDELLI, C, CERIBELLI, A, BIANCO, R, MARANGOLO, M, DI COSTANZO, F

Volltext

Nab-paclitaxel (nab-P) in metastatic breast cancer (MBC) in elderly patients: A real life setting (NEREIDE study) von Adamo, V., Ricciardi, G.R.R., Schifano, S., Russo, A., Gebbia, V., Blasi, L., Giuffrida, D., Scandurra, G., Savarino, A., Butera, A., Borsellino, N., Verderame, F., Caruso, M.

Volltext

Baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR) and platelet-to-lymphocyte ratio (PLR) and outcome in non small cell lung cancer (NSCLC) tre... von Russo, A., Scimone, A., Picciotto, M., Toscano, G., Raiti, F., Sava, S., Battaglia, A., Adamo, V.

Volltext

Efficacy and safety of the combination of pertuzumab (P) plus trastuzumab (T) plus docetaxel (D) for HER-2 positive metastatic breast cancer (MBC) in pretreated patients (pts) with... von Ricciardi, G, Ficorella, C, Iezzi, L, Marchetti, P, Pizzuti, L, Prestifilippo, A, Schifano, S, Maimone, S, Adamo, V

Volltext

Retrospective analysis of the therapeutic efficacy of platinum/etoposide schedules in the treatment of advanced poor differentiated neuroendocrine carcinomas of the lung von Chillari, F., Blanco, G., Russo, A., Puliafito, I., Munaò, S., Battaglia, A., Franchina, T., Castorina, L., Giuffrida, D., Adamo, V.

Volltext

Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maint... von Raimondi, A., Di Maio, M., Peverelli, G., Morano, F., Corallo, S., Bergamo, F., Cremolini, C., Smiroldo, V., Amatu, A., Tampellini, M., Fanchini, L., Murialdo, R., Clavarezza, M., Noventa, S., Adamo, V., Ratti, M., Petrelli, F., Antonuzzo, L., Palermo, M., de Braud, F., Di Bartolomeo, M., Pietrantonio, F.

Volltext

Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study von Adamo, V, Ricciardi, G, Schifano, S, Russo, A, Gebbia, V, Blasi, L, Giuffrida, D, Scandurra, G, Savarino, A, Butera, A, Borsellino, N, Verderame, F, Caruso, M

Volltext

Photochromic Switches Incorporated in Bridging Ligands: A New Tool to Modulate Energy-Transfer Processes von Belser, P., De Cola, L., Hartl, F., Adamo, V., Bozic, B., Chriqui, Y., Iyer, V. M., Jukes, R. T. F., Kühni, J., Querol, M., Roma, S., Salluce, N.

Volltext

Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy w... von Morano, F., Corallo, S., Di Bartolomeo, M., Lonardi, S., Cremolini, C., Rimassa, L., Sartore Bianchi, A., Murialdo, R., Zaniboni, A., Adamo, V., Tomasello, G., Tampellini, M., Fanchini, L., Schirripa, M., Clavarezza, M., Petrelli, F., Longarini, R., Cinieri, S., de Braud, F.G.M., Pietrantonio, F.

Volltext

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer von DI MAIO, M, GRIDELLI, C, FRONTINI, L, ROSETTI, F, CARROZZA, F, BEARZ, A, SPATAFORA, M, ADAMO, V, ISA, L, LAFFAIOLI, R. V, DI SALVO, E, PERRONE, F, GALLO, C, MANZIONE, L, BRANCACCIO, L, BARBERA, S, ROBBIATI, S. F, LANNIELLO, G. P, FERRAU, F, PIAZZA, E

Volltext

Prognostic impact of CD133 immunoexpression in node-negative invasive breast carcinomas von Ieni, A, Giuffrè, G, Adamo, V, Tuccari, G

Volltext

Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients von Adamo, V, Iorfida, M, Montalto, E, Festa, V, Garipoli, C, Scimone, A, Zanghì, M, Caristi, N

Volltext